- News & Analysis
- Home
- Global Corporate Venturing
- Global University Venturing
- Latest News
- Publications
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- Video
- Subscribe
- Newsletters
- Events
Page 45
Daily Deal Round Up: May 4, 2021
Solidia Technologies, Kelun Biotech and Doer Biologics all raised more than $70m while Sony added cash to a round valuing Discord at $7bn.
May 4, 2021Roivant engineers $7.3bn reverse takeover
Dexxon, SoftBank and Sumitomo Dainippon-backed medical company builder Roivant Sciences will get a public listing through the transaction.
May 4, 2021Sonder sends out $2.2bn reverse merger plans
The Lennar-backed accommodation provider will take a Nasdaq listing having previously raised $530m, and was valued at $1.3bn as of June 2020.
May 4, 2021Mobvista wins Reyun in $232m deal
Fosun is set to exit the mobile data-monitoring platform developer in an acqusition by Mobvista that will follow $36m of funding.
May 4, 2021Daily Deal Round Up: April 30, 2021
Driverless vehicle developer EasyMile closed a $66.4m round featuring Alstom and Continental while UCB and LivaNova-backed EEG technology developer Ceribell secured $53m.
Apr 30, 2021Tata gets assent for BigBasket majority purchase
Alibaba could potentially sell $550m of shares in the deal, which has been given approval by regulators and which will give Tata a 64% stake in return for $1.2bn.
Apr 30, 2021Daily Deal Round Up: April 29, 2021
Rakuten took part in a $37m round for virtual kitchen operator Taster while Nano Dimension is buying M12-backed 3D microprinter developer NanoFabrica for up to $54.9m.
Apr 29, 2021MessageBird's series C mushrooms to $1bn
Bonnier was among the investors that added $800m to the marketing technology provider's latest round, with $600m funding its purchase of SparkPost.
Apr 29, 2021Shapeways crystallises reverse merger details
Desktop Metal is backing a $75m PIPE supporting the reverse takeover, which values the additive manufacturing technology provider at $410m.
Apr 29, 2021Pfizer finds cash for Amplyx acquisition
Fungal infection treatment developer Amplyx Pharmaceuticals had disclosed $142m in funding from investors including Pfizer and Lundbeckfonden Ventures.
Apr 29, 2021
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.